Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Match Group Inc (MTCH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Match Group Inc — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while Match Group Inc trades at $42.39 (market cap $9.72B). The key difference: Hinge Health Inc. Class A Common Stock and Match Group Inc are close in size by market cap, and Match Group Inc pays a 1.89% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Match Group Inc for 115 Days on average.
| HNGE | MTCH | |
|---|---|---|
Market Cap | $8.47B | $9.72B |
Volume | 1,624,526 | 4,140,020 |
Sector | Health | Media |
52-Week High | $105.14 | $44.40 |
52-Week Low | $31.17 | $28.90 |
Typical Hold Time | 0 Days | 115 Days |
Enterprise Value | $8.09B | $12.69B |
Dividend Yield | — | 1.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
MTCH trades at $42.36, up 2.02% today, near the consensus price target of $42.29. The stock shows a bullish technical trend with support at $41 and resistance at $43. Recent earnings beat expectations in Q2 2026, and the company maintains strong profitability with a 74.8% gross margin. Positive sentiment is driven by Tinder's turnaround and Hinge's growth, with analyst consensus leaning Buy.
Outlook is cautiously optimistic with revenue stability and margin expansion potential. Key risks include high debt levels and competitive pressures. The absence of Sell ratings and institutional accumulation support a favorable medium-term view, but investors should monitor execution on product innovations and user growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Match Group Inc
Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
Read more on MTCH →
